- Home
- NVNO
as 11-21-2024 4:00pm EST
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 59.4M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 117.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.01 - $6.97 | Next Earning Date: | 10-31-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest enVVeno Medical Corporation News
NVNO Breaking Stock News: Dive into NVNO Ticker-Specific Updates for Smart Investing
ACCESSWIRE
2 days ago
enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium
ACCESSWIRE
3 days ago
enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
ACCESSWIRE
22 days ago
enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoValve in Q4 of this Year
ACCESSWIRE
25 days ago
enVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R)
ACCESSWIRE
2 months ago
enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering
ACCESSWIRE
2 months ago
enVVeno Medical Corporation Announces Proposed Public Offering
ACCESSWIRE
3 months ago
enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of Marketing
ACCESSWIRE
3 months ago
enVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)
Compare NVNO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NVNO enVVeno Medical Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.